Kairos Pharma, LTD. — All Filings
106 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
3
4
424B3
424B4
8-A12B
8-K
CERT
CORRESP
D
DEF 14A
DEF 14C
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
NT 10-K
PRE 14C
PRER14A
S-1
S-1/A
S-3
S-8
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DRSLTR | — | 0001493152-23-022727 | Jun 28, 2023 | — |
| DRS/A | — | 0001493152-23-022725 | Jun 28, 2023 | — |
| DRS/A | — | 0001493152-23-022724 | Jun 28, 2023 | — |
| D | — | 0001493152-23-013724 | Apr 27, 2023 | — |
| UPLOAD | — | 0000000000-23-004179 | Apr 25, 2023 | — |
| DRS | — | 0001493152-23-009350 | Mar 29, 2023 | — |